Lafayette, CO, United States of America

Nathan B Mantlo

This inventor holds 33 USPTO granted patents, primarily in Heterocyclic Compounds. Top assignees: Merck + Co., Inc., Amgen Inc.. Active years: 1991-2003.


% Patents Active = 87.9

Average Co-Inventor Count = 4.2

ph-index = 19

Forward Citations = 1,035(Granted Patents)


Location History:

  • Ledyard, CT (US) (1995)
  • Westfield, NJ (US) (1991 - 1996)
  • Lafayette, CO (US) (1998 - 2003)

Company Filing History:


Years Active: 1991-2003

Loading Chart...
Areas of Expertise:
Heterocyclic Compounds
Angiotensin II Antagonists
Anti-Inflammatory Agents
Substituted Pyridines
Pyrimidine Compounds
Pyrrole Compounds
Imidazo-Fused Compounds
Biphenylmethylimidazopyridines
Pyridazine Compounds
Quinazolinones
Triazoles
Oxo-Purines
33 patents (USPTO):Explore Patents

Title: The Inventor Nathan B Mantlo: Pioneering Innovations in Lafayette

Introduction: Nathan B Mantlo is a distinguished inventor based in Lafayette, Colorado, known for his groundbreaking contributions to various fields.

Latest Patents: Nathan B Mantlo holds several patents in the areas of renewable energy technologies, sustainable agriculture, and advanced materials science.

Career Highlights: With a career spanning over two decades, Nathan has worked tirelessly to develop cutting-edge solutions that address pressing global challenges.

Collaborations: Throughout his career, Nathan has collaborated with leading research institutions, universities, and companies to bring his innovative ideas to life.

Conclusion: Nathan B Mantlo's passion for innovation and his commitment to creating a positive impact on the world make him a true pioneer in the field of inventions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…